| 摘要 |
This invention is directed to modifying or regulating in a subject of at lea st one of lipid and glucose metabolism by administering to a subject in need of such treatment a dopamine D1 agonist in conjunction wit h one agent or agent combination selected from i) a dopamine D2 agonist, ii) at least one of an adrenergic alphal antagonist, an adrenerg ic alpha2 agonist and a serotonergic inhibitor, or iii) a dopamine D2 agonist further conjoined with at least one of an adrenergic alphal antagonist, an adrenergic alpha2 agonist and a serotonergic inhibitor.
|
